Skip to content

Shampa Ghosh

3 papers in the library · 57 citations · publishing 2023-2024

Papers

Sort Most recent Most cited

Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease‐Related Dementia

Alzheimer s & Dementia December 1, 2024 Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh et al. 1 citation

Abstract Background Traditionally associated with recreational and spiritual uses, psychedelics have gained attention in psychotherapy for their therapeutic potential. Functioning as potent 5‐hydroxytryptamine (5HT) agonists, these compounds have demonstrated the ability to enhance neural plasticity by activating serotoninergic and glutamatergic systems. Despite these recognized effects, their...

Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways

Ageing Research Reviews February 1, 2024 Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh et al. 29 citations

Psychedelics have traditionally been used for spiritual and recreational purposes, but recent developments in psychotherapy have highlighted their potential as therapeutic agents. These compounds, which act as potent 5-hydroxytryptamine (5HT) agonists, have been recognized for their ability to enhance neural plasticity through the activation of the serotoninergic and glutamatergic systems....

Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects.

Ibrain 2023 Bhuvi Sachdeva, Punya Sachdeva, Shampa Ghosh et al. 27 citations

Major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are the most common causes of emotional distress that impair an individual's quality of life. MDD is a chronic mental illness that affects 300 million people across the world. Clinical manifestations of MDD include fatigue, loss of interest in routine tasks, psychomotor agitation, impaired ability to focus, suicidal...